Lv1
48 积分 2022-07-01 加入
不可切除肺癌放疗联合免疫治疗专家共识(2024年版)
21小时前
待确认
Guidelines for the management of tumor-associated hyperglycemia (2021 edition)
3天前
已完结
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
17天前
已完结
Combinations of Bevacizumab With Immune Checkpoint Inhibitors in Renal Cell Carcinoma
17天前
已完结
Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer
24天前
已完结
Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer
24天前
已完结
[Consensus on immunotherapy for small cell lung cancer(2024 edition)]
2个月前
已完结
Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial
2个月前
已完结
Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives
2个月前
已完结
Safety and efficacy of antibody-drug conjugates plus immunotherapy in solid tumours: A systematic review and meta-analysis
2个月前
已完结
皖公网安备34019202002308
